DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 52 · January 2014 DOI: 10.1055/s-004-26267

30. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber

Tübingen, 24. – 25. 1. 2014
Kongresspräsident: Prof. Dr. Alfred Königsrainer


V_5_02
Bohne, F; Meyer, C; Quitt, O; Dhamodaran, A; Alvarez, L; Caballero, S; Guillamet, A; Bruss, V; Moldenhauer, G; Momburg, F; Protzer, U: Immunotherapeutic retargeting of effector cells towards HBV infected target cells using bispecific antibody constructs
V_5_03
Bruns, T; Zimmermann, HW; Li, KK; Trivedi, PJ; Pachnio, A; Reynolds, G; Hubscher, S; Moss, PA; Adams, DH: Virus Infection Of Hepatic Sinusoidal Endothelial Cells Regulates Hepatic T Cell Recruitment And Activation
P_5_03
P_5_04
Kefalakes, H; Jochum, C; Bohrer, AM; Hilgard, G; Kahraman, A; El Hindy, N; Heinemann, F; Gerken, G; Timm, J: Decades after spontaneous HBsAg clearance the CD8+ T cell immune response is less vigorous compared to chronic hepatitis B viral infection
P_5_05
Wenzel, JJ; Sichler, M; Schemmerer, M; Behrens, G; Leitzmann, MF; Jilg, W: Decline in Hepatitis E Virus (HEV) Antibody Prevalence in Southeastern Germany, 1996 – 2011
P_5_07
Schulze, K; Weismüller, T; Hübener, P; Zenouzi, R; Gotthardt, D; de Leuw, P; Bubenheim, M; Teufel, A; Zimmer, V; Lenzen, H; Reiter, F; Rust, C; Tharun, L; Quaas, A; Lammert, F; Galle, PR; Sarrazin, C; Manns, M; Lohse, AW; Schramm, C: Der Simplified AIH Score – Kriterium zur Einleitung einer Immunsuppression bei Patienten mit Primär Sklerosierender Cholangitis: Ergebnisse einer deutschen Multicenter Studie
P_5_08
Hermanns, NL; Cubero, FJ; Mohs, A; Ohl, K; Al Masaoudi, M; Lietdke, C; Tenbrock, K; Trautwein, C: Die CREMα-abhängige T-Zellantwort hemmt Progression der chronischen Lebererkrankung und deren Komplikationen
P_5_09
Krämer, B; Diegeler, S; Kokordelis, P; Glässner, A; Eisenhardt, M; Wolter, F; Boesecke, C; Goeser, F; Spengler, U; Rockstroh, JK; Nattermann, J: Die HIV-assoziierte Dysregulation der NKp46 Expression auf NK Zellen könnte die Suszeptibilität für HCV und deren Verlauf beeinflussen
P_5_10
Giersch, K; Homs, M; Volz, T; Allweiss, L; Lohse, AW; Buti, M; Petersen, J; Dandri, M; Lütgehetmann, M: Different antiviral effects induced by interferon or entecavir in HDV infected human-chimeric uPA/SCID mice determined by new intrahepatic qRT-PCR assay
P_5_12
Dammermann, W; Stiel, EM; Kohring, M; Schulze zur Wiesch, J; Lohse, AW; Lüth, S: Easy and robust testing of T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients
P_5_13
Solbach, P; Westhaus, S; Deest, M; Berg, T; Manns, MP; Sarrazin, C; Ciesek, S; Hahn, T von: Endogenous oxidized LDL levels predict treatment response in interferon-based therapy of chronic hepatitis C
P_5_16
Ingiliz, P; Rockstroh, JK; Nelson, M; Soriano, V; Arastéh, K; Guardiola, J; Bhagani, S; Mallolas, J; Tural, C; Puoti, M; Battegay, M; Jain, MK; Nunez, M; Marks, K; Kort, J; Stern, J; Vinisko, R; Manero, M; Dieterich, D: Faldaprevir plus pegyliertes Interferon alpha-2a und Ribavirin (PR) bei Patienten mit HIV und Hepatitis C Genotyp (GT)-1 Koinfektion: End of Treatment Response (ETR) – Ergebnisse der Phase III Studie STARTVerso 4
P_5_20
P_5_21
Rau, M; Schmitt, J; Kudlich, T; Marin, JJG; Rodríguez Romero, M; Klinker, H; Tony, HP; Müllhaupt, B; Geier, A: Higher frequency of peripheral CD3CXCR3 and CD4CXCR3 positive blood cells in HCV patients in context of bile acid retention
P_5_22
Russo, C; Dembek, C; Geisler, F; Umgelter, A; Draenert, R; Protzer, U; Bauer, T: HIV-1 infection impairs frequency and functionality of HBV-specific CD4 T cells in patients with chronic hepatitis B
P_5_24
Langhans, B; Alwan, AW; Althausen, E; Krämer, B; Glässner, A; Nattermann, J; Strassburg, C; Spengler, U: IL-8 hemmt die Suszeptibilität von CD56hochCD16negativ NK-Zellen gegenüber primären humanen hepatischen Sternzellen (HSC)
P_5_26
Broering, R; Trippler, M; Real, CI; Lutterbeck, M; Kleinehr, K; Poggenpohl, L; Gerken, G; Schlaak, JF: Interferon stimulated gene 15, a proviral factor in hepatitis C virus replication, is regulated by the Proteasome subunit alpha type-6
P_5_27
Thoens, C; Berger, C; Trippler, M; Siemann, H; Lutterbeck, M; Broering, R; Schlaak, JF; Heinemann, FM; Heinold, A; Nattermann, J; Scherbaum, N; Alter, G; Timm, J: KIR2DL3+ NKG2A- Natural Killer Cells Protect People who Inject Drugs against Productive Hepatitis C Virus Infection
P_5_28
Bovensiepen, C; Sebode, M; Sospedra, M; Martin, R; Lohse, AW; Schramm, C; Herkel, J; Weiler-Normann, C: Leberinfitrierende CD4 T Zellen bei der autoimmunen Hepatitis zeigen ein distinktes TH1 Profil
P_5_29
Karimi, K; Kessler, T; Ramisch, K; Tasika, E; Arck, P; Tiegs, G: Maternal Liver Damage Programs Offspring Allergic Inflammation in Mice
P_5_30
Haxthausen, F von; Schwinge, D; Quaas, A; Huber, S; Herkel, J; Lohse, AW; Schramm, C: Modulation von regulatorischen T Zellen im Mausmodell der Primär Sklerosierenden Cholangitis
P_5_31
Hoyo-Becerra, C; Liu, ZJ; Gerken, G; Hermann, DM; Schlaak, JF: New mouse model mimicking IFN-related depression in HCV patients
P_5_32
Lang, PA; Xu, HC; Grusdat, M; Parish, I; Recher, M; Elford, A; Dhanji, S; Shaabani, N; Tran, CW; Dissanayake, D; Rahbar, R; Ghazarian, M; Brustle, A; Fine, J; Chen, P; Weaver, CT; Klose, C; Diefenbach, A; Carlyle, JR; Kaech, SM; Mak, TW; Ohashi, PS; Häussinger, D; Lang, KS: NK cell activity promotes liver damage and chronic viral infection
P_5_33
Kokordelis, P; Krämer, B; Boesecke, C; Glässner, A; Eisenhardt, M; Voigt, E; Ingiliz, P; Wolter, F; Strassburg, CP; Rockstroh, JK; Spengler, U; Nattermann, J: Phänotypische und funktionelle Analyse von natürlichen Killer T (NKT)-Zellen bei HIV-Patienten mit einer akuten Hepatitis C
P_5_34
Nischalke, HD; Lutz, P; Berger, C; Langhans, B; Hoerauf, A; Grünhage, F; Appenrodt, B; Lammert, F; Nattermann, J; Sauerbruch, T; Strassburg, CP; Spengler, U: Polymorphsims in the farnesoid X receptor modify the risk for spontaneous bacterial peritonitis in cirrhotic patients
P_5_38
Wiegand, SB; Bremer, B; Geipel, A; Bremer, CM; Wranke, A; Heidrich, B; Manns, MP; Wedemeyer, H; Glebe, D; Cornberg, M: Quantification of Large, Middle and Small Hepatitis B virus (HBV) surface protein (HBsAg) fractions in patients with Hepatitis Delta
P_5_39
Xu, HC; Mcllwain, DR; Pandyra, AA; Recher, M; Brenner, D; Häussinger, D; Ohashi, PS; Mak, TW; Lang, KS; Lang, PA: Reactive oxygen species delay control of lymphocytic choriomeningitis virus
P_5_40
P_5_41
Werner, JM; Serti, E; Chepa-Lotrea, X; Stoltzfus, J; Ahlenstiel, G; Feld, JJ; Liang, JT; Rotman, Y; Rehermann, B: Ribavirin Pretreatment Improves the IFN-γ Response of Natural Killer Cells to IFN-based Therapy of Hepatitis C Virus Infection
P_5_42
Sprinzl, MF; Grambihler, A; Ehrlich, A; Kittner, J; Ebert, M; Zeuzem, S; Cornberg, M; Lohmeyer, J; Tacke, F; Eisenbach, C; Geisler, F; Spengler, U; Schott, E; Galle, PR: Safety of add on Interferon-alpha-2a in hepatitis B patients receiving effective nucleos(t)de therapy: Interim results from the German multicenter PADD-ON trial
P_5_43
Matono, T; Churin, Y; Reinhard, H; Roderfeld, M; Schröder, D; Zahner, D; Glebe, D; Roeb, E: Signaling pathways involved in carcinogenesis in a double hit mouse model of cholangiopathy and hepatitis B virus
P_5_45
Krebs, K; Böttinger, N; Huang, LR; Chmielewski, M; Arzberger, S; Gasteiger, G; Bohne, F; Aichler, M; Uckert, W; Abken, H; Heikenwälder, M; Knolle, P; Protzer, U: T cells redirected by a chimeric antigen receptor efficiently control Hepatitis B Virus replication in an immunocompetent mouse model
P_5_46
Oehler, N; Volz, T; Kah, J; Giersch, K; Allweiss, L; Petersen, J; Lohse, AW; Lütgehetmann, M; Heeren, J; Dandri, M: The expression profile of bile acid and cholesterol synthesis genes are affected by the binding of Hepatitis B Virus to its cellular receptor
P_5_47
Behrendt, P; Dörrbecker, J; Steinmann, E; Hügging, K; Menzel, N; Grabski, E; Rogalska-Taranta, M; Pfaender, S; Kalinke, U; Wedemeyer, H; Manns, MP; Pietschmann, T: The impact of adipokines hormones on HCV life-cycle
P_5_48
Ehlting, C; Trilling, M; Tiedje, C; Zimmermann, A; Le, VTK; Gaestel, M; Hengel, H; Häussinger, D; Bode, JG: The MAPKAP kinase 2 controls IL-10 expression and protects from liver injury upon cytomegalovirus infection
P_5_50
Real, CI; Broering, R; Jahn-Hofmann, K; Ickenstein, L; John, M; Kleinehr, K; Driftmann, S; Kemper, T; Vornlocher, HP; Schirmbeck, R; Lu, M; Gerken, G; Schlaak, JF: Toll-like receptor 3 activation mediates the expression of interferon and interferon stimulated genes during hepadnaviral replication in HBV-transgenic mice lacking the HBs-antigen
P_5_51
Kozik, JH; Trautmann, T; Carambia, A; Eissing, L; Lohse, AW; Wiegard, C; Heeren, J; Herkel, J: TREM1-Defizienz begünstigt die vorzeitige Klärung einer Virushepatitis im Mausmodell